Extension Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy
- NCT ID
- NCT01239758
- Sponsor
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
- Registry dates
- 2010-10 – 2011-05
- Enrollment
- 11 registered participants
- Locations
- Canada
- Conditions listed
- Duchenne Muscular Dystrophy
